MicroRNA-sensitive Oncolytic Measles Viruses for Cancer-specific Vector Tropism

This publication has 55 references indexed in Scilit:

• Mantle cell lymphoma salvage regimen: synergy between a reprogrammed oncolytic virus and two chemotherapeutics
  Gene Therapy, 2010
• Treatment of medulloblastoma with a modified measles virus
  Neuro-Oncology, 2010
• Oncolytic measles viruses encoding interferon β and the thyroidal sodium iodide symporter gene for mesothelioma virotherapy
  Cancer Gene Therapy, 2010
• Post-transcriptional Regulation of α-Synuclein Expression by mir-7 and mir-153
  Journal of Biological Chemistry, 2010
• Repression of α-synuclein expression and toxicity by microRNA-7
  Proceedings of the National Academy of Sciences, 2009
• Engineered measles virus as a novel oncolytic therapy against prostate cancer
  The Prostate, 2008
• Toxicology Study of Repeat Intracerebral Administration of a Measles Virus Derivative Producing Carcinoembryonic Antigen in Rhesus Macaques in Support of a Phase I/II Clinical Trial for Patients with Recurrent Gliomas
  Human Gene Therapy, 2008
• Preclinical Pharmacology and Toxicology of Intravenous MV-NIS, an Oncolytic Measles Virus Administered With or Without Cyclophosphamide
  Clinical Pharmacology & Therapeutics, 2007
• A Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing
  Cell, 2007
• Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses
  Proceedings of the National Academy of Sciences, 2006